Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $500.00 | 1 | 51.1% |
| Food and Beverage | $479.03 | 5 | 48.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $727.04 | 3 | $0 (2021) |
| Neurocrine Biosciences, Inc. | $232.74 | 2 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $19.25 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $232.74 | 2 | Neurocrine Biosciences, Inc. ($232.74) |
| 2021 | $112.09 | 1 | Supernus Pharmaceuticals, Inc. ($112.09) |
| 2020 | $19.25 | 1 | Janssen Pharmaceuticals, Inc ($19.25) |
| 2019 | $614.95 | 2 | Supernus Pharmaceuticals, Inc. ($614.95) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/02/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | Cash or cash equivalent | $110.47 | General |
| Category: Neuropsychiatry | ||||||
| 07/14/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | Cash or cash equivalent | $122.27 | General |
| Category: Neuropsychiatry | ||||||
| 08/18/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | In-kind items and services | $112.09 | General |
| Category: PSYCHOLOGY | ||||||
| 02/13/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Neuroscience | ||||||
| 10/30/2019 | Supernus Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| 10/30/2019 | Supernus Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $114.95 | General |
About Dr. Elizabeth Cottingham, MD
Dr. Elizabeth Cottingham, MD is a Psychiatry healthcare provider based in Napa, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881773406.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elizabeth Cottingham, MD has received a total of $979.03 in payments from pharmaceutical and medical device companies, with $232.74 received in 2022. These payments were reported across 6 transactions from 3 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($500.00).
Practice Information
- Specialty Psychiatry
- Other Specialties Child & Adolescent Psychiatry
- Location Napa, CA
- Active Since 11/03/2006
- Last Updated 04/08/2022
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1881773406
Products in Payments
- INGREZZA (Drug) $232.74
- QELBREE (Drug) $112.09
- SPRAVATO (Drug) $19.25
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Napa
Noorulain Aqeel, Md, MD
Psychiatry — Payments: $23,689
Javed Iqbal, Md, MD
Psychiatry — Payments: $7,366
Cristian Mateescu, Md, MD
Psychiatry — Payments: $6,730
Dr. Maria Ilano, M.d, M.D
Psychiatry — Payments: $3,784
Dr. Robert Loman, M.d, M.D
Psychiatry — Payments: $3,445
Michael Loose, Md, MD
Psychiatry — Payments: $2,318